Literature DB >> 12042987

Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy.

Jeong-Sik Yu1, Ki Whang Kim, Mi-Gyoung Jeong, Deok Hee Lee, Mi-Suk Park, Sang-Wook Yoon.   

Abstract

The purpose of this study was to investigate the predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for treatment of hepatic malignancy. For patients (n = 31) with TACE-related bile duct injuries during a 36-month period, final diagnoses of the tumor, the liver profile, presence of portal vein thrombosis, total number and mode of the TACE just before the development of bile duct injury were compared, respectively with those of patients without bile duct injury n = 234) after TACE. The incidence of bile duct injury was higher in the patients with non-hepatocellular tumors than in patients with hepatocellular carcinoma (p <0.01), and higher in Child-Pugh class A patients than in B or C patients (p <0.01). Segmental or subsegmental TACE tended to induce bile duct injury more frequently than the proximal TACE (p = 0.01). Portal vein thrombosis, the total number of TACEs, total amount of iodized oil, and the usage of gelatin sponge were not closely related to bile duct injuries after TACE (p >0.05). It was concluded that the chance of bile duct injury after TACE is increased in non-cirrhotic livers with good liver profile and to the more selective embolization of distal arterial branches.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042987     DOI: 10.1007/s00270-001-0049-z

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  18 in total

1.  Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.

Authors:  Nikhil Bhagat; Diane K Reyes; Mingde Lin; Ihab Kamel; Timothy M Pawlik; Constantine Frangakis; J F Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2012-06-22       Impact factor: 2.740

2.  Biliary complications associated with selective internal radiation (SIR) therapy for unresectable liver malignancies.

Authors:  Simon S M Ng; Simon C H Yu; Paul B S Lai; W Y Lau
Journal:  Dig Dis Sci       Date:  2008-03-05       Impact factor: 3.199

Review 3.  Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings.

Authors:  J Chung; J-S Yu; J-J Chung; J H Kim; K W Kim
Journal:  Br J Radiol       Date:  2009-07-06       Impact factor: 3.039

4.  Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.

Authors:  Bruno C Odisio; Aaron Ashton; Yuanqing Yan; Wei Wei; Ahmed Kaseb; Michael J Wallace; Jean N Vauthey; Sanjay Gupta; Alda L Tam
Journal:  J Vasc Interv Radiol       Date:  2015-06-05       Impact factor: 3.464

5.  Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management.

Authors:  Bo Zhang; Yongjian Guo; Ketong Wu; Hong Shan
Journal:  Mol Clin Oncol       Date:  2017-05-04

6.  Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.

Authors:  Timm Kirchhoff; Lars Zender; Sonja Merkesdal; Bernd Frericks; Nisar Malek; Joerg Bleck; Stefan Kubicka; Stefan Baus; Ajay Chavan; Michael-P Manns; Michael Galanski
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations.

Authors:  Sung Ho Hwang; Jeong-Sik Yu; Jin Chung; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

8.  Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.

Authors:  Carsten Meyer; Claus Christian Pieper; Samer Ezziddin; Kai E Wilhelm; Hans Heinz Schild; Hojjat Ahmadzadehfar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

9.  Angiogenesis and proliferation of bile duct enhances ischemic tolerance in rats with cirrhosis.

Authors:  Zhiqiang Zhang; Zhennan Li; Chen Zou; Jingjing Zhang; Yi Zhu; Yi Miao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

10.  The Risk Assessment and Clinical Research of Bile Duct Injury After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.

Authors:  Houyun Xu; Xiping Yu; Jibo Hu
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.